Search

Lonza Group AG

Gesloten

SectorGezondheidszorg

569.4 -1.86

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

567.4

Max

582.79

Belangrijke statistieken

By Trading Economics

Inkomsten

88M

571M

Verkoop

419M

3.4B

K/W

Sectorgemiddelde

37.272

56.659

Dividendrendement

0.86

Winstmarge

16.924

Werknemers

20,141

EBITDA

321M

1.1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+19.98% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.86%

2.18%

Volgende Winsten

22 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

810M

40B

Vorige openingsprijs

571.26

Vorige sluitingsprijs

569.4

Nieuwssentiment

By Acuity

16%

84%

27 / 339 Rangschikking in Healthcare

Lonza Group AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 sep 2026, 23:56 UTC

News

Missouri American Water acquired Neosho's water systems for $34.5 million, adding 5,400 customers. Shares of American Water Works traded higher in after-market hours.

3 sep 2026, 23:56 UTC

News
Correlated Moves

Paychex receives a buy rating on strong revenue growth and strategic AI integration. After-market trading has shown little change since Thursday's close.

3 sep 2026, 23:56 UTC

News

Jefferies initiated coverage on Nexgen Energy with a Buy rating and a C$21 price target. Shares moved higher in after-market hours.

3 sep 2026, 23:51 UTC

News

Regeneron Pharmaceuticals faces a class action lawsuit over misleading statements about its Phase III Fianlimab-Libtayo Study, with shares trading lower in after-market hours.

3 sep 2026, 23:51 UTC

News
Social Media

Dutch Bros Inc filed a mixed securities shelf registration, enabling potential issuance of various securities. Shares are trading higher in after-market hours.

3 sep 2026, 23:51 UTC

News
Social Media

Tesla Inc. shares are lower in after-market trading following the invite-only launch event for its Cybercab in Austin, as details remain restricted.

3 sep 2026, 23:46 UTC

News

Weyerhaeuser Co remains about 4.95% below its 20-day moving average. Shares were roughly flat in after-market hours following a price target cut to $28.

3 sep 2026, 23:46 UTC

News
Social Media

Hewlett Packard Enterprise shares are lower in after-market trading, despite strong networking revenue guidance and broader market gains ahead of employment data.

3 sep 2026, 23:41 UTC

News

JP Morgan upgrades CPRT to Overweight, raises target to $40 after-market.

3 sep 2026, 23:41 UTC

News

Johnson & Johnson's shares are lower in after-market trading following FDA approval of IMAAVY and a jury verdict in a talc case.

3 sep 2026, 23:36 UTC

News

Ulta Beauty will participate in a Fireside Chat at the Barclays Global Consumer Conference on September 10, 2026. Shares are higher in after-market trading.

3 sep 2026, 23:31 UTC

News

Honeywell International Inc shares are lower in after-hours trading, despite broader market gains. The stock is near the lower end of its one-month range.

3 sep 2026, 23:26 UTC

News

Jefferies maintained a Buy rating on Five Below and raised its price target to $420. Shares are trading higher in after-market hours following the updates.

3 sep 2026, 23:21 UTC

News
Social Media

Meta Platforms Inc. shares are higher in after-market hours, supported by a Buy rating from Bank of America with a price target of $810.

3 sep 2026, 23:21 UTC

News

Thermo Fisher Scientific shares are lower in after-market hours despite CLSA initiating coverage with an Outperform rating and a $748 price target.

3 sep 2026, 23:11 UTC

News

Ethereum is trading higher during Thursday's session, remaining above its 20-day moving average and near the upper end of its one-month range.

3 sep 2026, 23:11 UTC

News

Ethereum is trading higher today, remaining above its 20-day moving average and near the upper end of its one-month trading range.

3 sep 2026, 23:05 UTC

News

USD/HKD trades roughly flat amid stable market activity. An increase in USDE supply to $4.26 billion may influence dynamics but has not impacted prices today.

3 sep 2026, 23:05 UTC

News

WEX Inc. shares decline in after-market hours despite announcing an integration with Driivz Ltd. for electric vehicle charging solutions, with a fair value of $187.30.

3 sep 2026, 23:05 UTC

Correlated Moves
News

Elastic NV plans to integrate OpenAI GPT cyber models into its Elastic Security platform, enhancing security capabilities. Shares are trading roughly flat in after-market hours.

3 sep 2026, 23:05 UTC

Macro Event
Correlated Moves
News

The USD/PLN exchange rate is declining amid mixed U.S. jobless claims data, with initial claims rising slightly above expectations.

3 sep 2026, 23:02 UTC

News
Social Media

Lululemon Athletica reported second-quarter revenue of $2.42 billion, below estimates. The stock fell sharply in after-market hours, reaching its lowest level since May 2018.

3 sep 2026, 23:02 UTC

News
Correlated Moves
Social Media

DocuSign shares rise in after-market trading following strong fiscal Q2 results and raised revenue guidance, despite earlier pulling back from a session high.

3 sep 2026, 23:01 UTC

News

PulteGroup Inc shares are higher in after-market hours following a Buy rating from StoneX analyst Michael, who set a price target of $148.00.

3 sep 2026, 23:01 UTC

News

eGain Corp shares are lower in after-market trading following disappointing fiscal 2027 guidance, despite reporting revenue and adjusted EPS that exceeded estimates.

3 sep 2026, 23:01 UTC

News

Concrete Pumping Holdings reported strong Q3 results, raising revenue guidance and announcing a quarterly dividend, driving shares higher in after-market trading.

3 sep 2026, 23:01 UTC

News
Social Media
Event

UiPath Inc shares declined in after-market hours despite reporting second-quarter revenue of $410 million and raising its fiscal year 2027 outlook.

3 sep 2026, 23:01 UTC

News
Event

Oxford Industries reports second-quarter sales of $394 million and lowers full-year adjusted EPS guidance to $1.60-$2.00, leading shares lower in after-market hours.

3 sep 2026, 23:01 UTC

News
Social Media

Strategy Inc shares declined after hours, retracing from earlier gains amid social media discussions and news from Iran affecting sentiment.

3 sep 2026, 23:01 UTC

News
Event
Social Media

Smith & Wesson Brands reported strong Q1 results, with net sales of $112.6 million and adjusted EPS of $0.06, boosting shares in after-market trading.

Peer Vergelijking

Prijswijziging

Lonza Group AG Prognose

Koersdoel

By TipRanks

19.98% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 698.29 CHF  19.98%

Hoogste 781 CHF

Laagste 640 CHF

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Lonza Group AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

27 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
help-icon Live chat